G protein-coupled receptors (GPCR) 2 belong to the largest superfamily of plasma membrane proteins, accounting for Ͼ1% of the human genome (2) . GPCRs transduce extracellular signals into intracellular effectors and control a number of physiological responses, including vision, cognition, metabolism, cardiac function, and neurotransmission (3). Abnormal and/or dysregulated GPCR signaling has been associated with many human diseases, including various types of cancer.
GPCRs are activated at the plasma membrane by agonist binding. Following a change in the conformation of the receptors, GPCRs couple to heterotrimeric G proteins and initiate a variety of downstream signaling pathways (4) . Receptor responsiveness is subsequently attenuated, a concept defined as receptor desensitization, by receptor phosphorylation, arrestin binding, and clathrin-mediated endocytosis (5) . Interestingly, in addition to signal transduction cascades initiated at the plasma membrane, some receptors may continue to signal from endocytic compartments in a G protein-independent manner. It is now well established that GPCR trafficking is a critical factor that determines spatial and temporal control of GPCR signaling.
Once internalized, GPCRs are sorted in the early endosomes to either recycling pathways leading to receptor resensitization, or sorted for down-regulation in lysosomes, which permanently terminates receptor signaling. Lysosomal sorting of a number of GPCRs involves a covalent modification of receptors with ubiquitin (6) . Although some ubiquitin ligases have been identified, future work is required to further characterize and define the specific details of sorting of ubiquitinated GPCRs. In that regard, it has been reported that ubiquitination and downregulation of protease-activated receptor 2 is mediated by c-Cbl (7), the ubiquitin ligase that is known to regulate sorting of receptor tyrosine kinases to lysosomes (8) . Receptor recycling to the plasma membrane, on the other hand, was initially thought to occur via bulk membrane flow. Recent studies, however, revealed that GPCR recycling was a highly specific process. It appeared that specific amino acids residues of GPCRs and interactions with certain sorting proteins were required for efficient trafficking of internalized receptors to the plasma membrane (9) .
Previously, others have identified some GPCR interacting proteins involved in determining the fate of GPCRs. However, many aspects of GPCR intracellular trafficking remain mysterious. We have recently characterized a novel role for c-Cbl (ubiquitin ligase) in the active sorting of the epidermal growth factor receptor (EGFR) to recycling endosomes. Although, c-Cbl was implicated in mediating lysosomal degradation of some GPCRs (7) , possible roles for c-Cbl in GPCR recycling have not yet been addressed. We report here that c-Cbl interacts the 5-HT 2A receptor and that the carboxyl-terminal domain of c-Cbl regulates efficient 5-HT 2A R recycling to the plasma membrane and receptor resensitization. Taken together, these results implicate c-Cbl in a novel sorting pathway of 5-HT 2A R intracellular trafficking.
EXPERIMENTAL PROCEDURES
Materials-Human embryonic kidney (HEK293) cells were purchased from American Type Culture Collection (Manassas, VA). Serotonin, cyclohexamide, and probenecid were purchased from Sigma. Rabbit polyclonal anti-Rab11, mouse monoclonal anti-v5, rabbit polyclonal anti-GFP antibodies, and Alexa Fluor-conjugated secondary antibodies were from Invitrogen. Rabbit polyclonal anti-early endosome antigen 1 (EEA1) (clone H-300) antibody was from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal anti-c-Cbl antibody was from BD Biosciences. Rabbit polyclonal anti-lysosome-associated membrane protein (LAMP) and rabbit polyclonal mannose 6-phosphate receptor (M6PR) antibodies were from Abcam (Cambridge, MA). Mouse monoclonal anti-ubiquitin (clone FK2) antibody was from Biomol (Plymouth Meeting, PA). Mouse monoclonal anti-␤-actin (clone AC-15) antibody was from Sigma. Peroxidase-labeled secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA). SDS-PAGE molecular weight markers were from Bio-Rad.
Cell Culture, RNA Interference Experiments, and DNA Transfection-HEK293 cells were grown in Eagle's minimum essential medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen) at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Cells were grown to ϳ75% confluence and placed in serum-deprived binding media (minimum essential medium supplemented with 0.1% bovine serum albumin) for 24 h prior to treatments. In all experiments 100 g/ml of cycloheximide, a protein synthesis inhibitor, was used 3 h prior to and during treatments. For synchronized ligand pulse experiments, cells at 4°C were incubated with an agonist for 60 min in serum-deprived binding medium containing 20 mM HEPES, pH 7.4. Then, the cells were rinsed with ice-cold PBS to remove unbound ligand, following which the bound ligand stimulated 5-HT 2A R upon exposure to pre-warmed ligand-free medium at 37°C.
A mixture of four SMARTselection-designed siRNAs targeting one gene (Thermo Fisher Scientific, Lafayette, CO) were transfected using Oligofectamine (Invitrogen) reagent according to the manufacturer's instructions. A pool of 4 siGenome non-targeting siRNAs, designated as scrambled (SCR) siRNA, was used as control. 72 h following transfection, cell lysates were assayed for silencing effectiveness by Western blotting and immunofluorescence staining.
The expression constructs pcDNA 3 GFP-Cbl-WT, pcDNA 3 -GFP-Cbl-(1-436), and pcDNA 3 GFP-Cbl-N have been described previously and kindly provided by Dr. Hamid Band (10, 11). 5-HT 2A R was cloned in-frame with the v5 epitope into the pEF6/V5-His TOPO vector using a pEF6/V5-His TOPO TA Expression Kit (Invitrogen). The 5-HT 2A R-YFP receptor construct was generated by cloning the cDNA sequence of human 5-HT 2A R into XhoI and BamHI sites of EYFP-N1 vector (Clontech, BD Biosciences, Franklin Lakes, NJ). HEK293 cells were transiently transfected with the above constructs using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen). Initial comparison revealed no difference between mock-and non-transfected cells. Thus, non-transfected cells were subsequently used as controls.
Western Blotting-After treatments, cells were rinsed briefly with PBS and extracted with RIPA buffer (150 mM NaCl, 1 mM EDTA, 0.25% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS in PBS) containing protease inhibitors. Cells were subsequently sonicated, and protein concentrations were determined by the BCA assay (Pierce). Equal amounts of proteins were separated by SDS-PAGE on 4 -12% polyacrylamide gels (Invitrogen), transferred to PVDF membranes, and blocked with 5% milk in PBS for 1 h at room temperature. Following several washes with PBS containing 0.1% Tween, the membranes were incubated with the appropriate dilutions of primary and peroxidase-conjugated secondary antibodies (as directed by the manufacturer) in blocking solution. Immunoblotted proteins were detected using ECL reagents (GE Healthcare).
Immunofluorescence Staining and Confocal MicroscopyCells were grown on 35-mm lysine-coated, glass-bottom culture dishes (MatTek Corporation, Ashland, MA). After treatments, cells were fixed with freshly prepared 3.7% paraformaldehyde in PBS for 15 min at room temperature. Subsequently, cells were permeabilized with 0.1% Triton X-100 (Sigma) in PBS for 5 min, following which nonspecific binding sites were blocked with 3% normal serum (Santa Cruz Biotechnologies) in PBS for 1 h. Incubations with the appropriate dilutions of primary and Alexa Fluor-conjugated secondary antibodies (as directed by the manufacturer) were performed in blocking solution. Confocal microscopy was performed using a Zeiss LSM 510 META laser-scanning microscope (Carl Zeiss, Inc., Thornwood, NY) equipped with a ϫ60 objective, using the following laser wavelengths: excitation 488 nm, emission 505-530 nm; excitation 543 nm, emission 560 -615 nm; excitation 633 nm, emission 630 -700 nm. Quantifications of the colocalization coefficients, derived from measured pixel overlaps between 5-HT 2A R and EEA1, Rab11, M6PR, and LAMP, were performed using Zeiss LSM 510 colocalization analysis software. The mean values were averaged from at least 16 independent single cell images.
Immunoprecipitation-After the indicated treatments, HEK293 cells grown in 100-mm dishes were scraped into icecold PBS and centrifuged at 10,000 ϫ g. Pellets were lysed in 1 ml of RIPA lysis buffer supplemented with protease and phosphatase inhibitors, as described above. Equal amounts of proteins were precleared by incubation for 60 min at 4°C with normal mouse or rabbit IgG (Santa Cruz Biotechnologies, Santa Cruz, CA). After a brief centrifugation, the supernatants were removed and incubated overnight at 4°C with either anti-v5 or anti-GFP antibodies. Immunoprecipitates were captured with 50 l of either protein A/G-agarose (Santa Cruz Biotechnology), or TrueBlot Ig IP beads (eBioscience, San Diego, CA) at 4°C for 1 h. The samples were then centrifuged and washed 4 times with 1 ml of RIPA buffer. Proteins were eluted from the beads using Laemmli sample buffer. Samples were subsequently analyzed by SDS-PAGE and Western blotting. The membranes were incubated with the appropriate dilutions of primary and TrueBlot peroxidase-conjugated secondary antibodies (eBioscience, San Diego, CA) (as directed by the manufacturer) in blocking solution.
Cell Surface Reversible Biotinylation-Attenuated receptor recycling was measured biochemically by the gain of intracellular receptors, which had been labeled with disulfide-linked (cleavable) biotin, following biotin stripping. Briefly, HEK293 cells were surface biotinylated with 0.5 mg/ml of cell-impermeable sulfo-NHS-S-S biotin (Pierce) in PBS for 30 min at 4°C. Excess biotin was subsequently quenched by washing with icecold 15 mM glycine. Cells were washed with PBS and incubated in serum-free medium at 37°C for 1 h prior to treatments. Cells were then incubated on ice with 1 M 5-HT for 60 min, washed free of unbound ligand, and either collected following stripping of cell surface biotin (biotin removed), or collected without biotin stripping (cell surface receptors), or collected following exposure to prewarmed ligand-free medium at 37°C for 180 min and cell surface biotin stripping (intracellular receptors). Stripping of cell surface-biotinylated receptors was performed at 4°C by washing the cells three times for 5 min with ice-cold GSH cleavage buffer (50 mM GSH, 75 mM NaCl, 1 mM EDTA, 1% BSA, 0.75% 10 N NaOH). Cell lysates were subsequently subjected to avidin precipitation and immunoblotting.
Intracellular Calcium Measurements-Cells were grown in lysine-coated 96-well clear-bottom black plates (Greiner BioOne, Monroe, NC). After treatments, cells were loaded with Calcium 3 dye (Molecular Devices, Sunnyvale, CA) for 60 min at 37°C in Hanks' balanced salt solution containing 2.5 mM probenecid. The changes in intracellular calcium were detected with fluorometric imaging plate reader (Molecular Devices, Sunnyvale, CA).
Statistical Analyses-Statistical significance was determined using analysis of variance with Dunnett's or Bonferroni posttest to correct for multiple comparisons (GraphPad Prism, version 4). p values of Ͻ0.05 were considered statistically significant. 2A R Trafficking-First, we evaluated the ability of serotonin to induce 5-HT 2A R endocytosis and intracellular trafficking in HEK293 cells. To minimize the effects of simultaneous 5-HT 2A R processing, i.e. receptor endocytosis, sorting, recycling, and/or degradation, we performed a synchronized ligand pulse experiment, as described previously (12), with some modifications successfully characterized by us (1). This protocol allowed us to track a single cohort of liganded receptors. Briefly, the cells transiently transfected with v5-tagged 5-HT 2A R were allowed to bind the ligand (1 M 5-HT) at 4°C for 60 min, following which the unbound ligand was removed and the cells were transferred to 37°C to initiate synchronous 5-HT 2A R processing (Fig. 1A) . We observed that at 0 min 5-HT 2A R was mostly localized to the plasma membrane (Fig. 1A, 0 min) . Some 5-HT 2A receptors also were detected intracellularly, which is indicative of consti- tutive receptor activity (13) . Ten min after the synchronous ligand pulse, there was considerable movement of the 5-HTstimulated 5-HT 2A R into intracellular compartments (Fig. 1A , 10 min), with nearly complete internalization after 30 min (Fig.  1A , 30 min). Three hours following rewarming of the cells, the majority of 5-HT 2A R re-appeared on the plasma membrane, with no detectable receptor degradation (Fig. 1A, 180 min) . There was minimal internalization of 5-HT 2A R in the absence of ligand (not shown), so the internalization of the receptors was the result of stimulation by 5-HT.
RESULTS

Effects of Serotonin (5-HT) on 5-HT
To confirm our microscopy observations, we sought to determine the degree of 5-HT 2A R down-regulation by means of immunoprecipitation with a monoclonal antibody directed against v5-tagged 5-HT 2A R (Fig. 1B) . This analysis revealed that treatment with 1 M 5-HT for 180 min resulted in little or no change in the immunoreactivity of 5-HT 2A receptors.
We later focused our efforts on determining the intracellular localization of 5-HT 2A receptors following a 30-min synchronized pulse of 5-HT. For these studies, we utilized various markers of subcellular organelles, i.e. EEA1 for early endosomes, Rab11 for the perinuclear slow recycling compartment, M6PR for late endosomes, and LAMP for lysosomes ( Fig. 2A) . These data show partial and high colocalization patterns of 5-HT 2A R with EEA1 and Rab11, respectively, and no apparent colocalization with either M6PR or LAMP. Our microscopy observations were confirmed by evaluation of the colocalization coefficients, which measured pixel overlap between the 5-HT 2A receptors and EEA1, Rab11, M6PR, or LAMP, respectively (Fig. 2B) . Taken together, these results demonstrate that 5-HT-activated 5-HT 2A receptors undergo endocytosis and are recycled via EEA1-and Rab11-positive intracellular compartments back to the plasma membrane. 2A R with c-Cbl-Previously, we documented a global role for c-Cbl in the regulation of vesicular sorting of EGFR (1). Thus, in this work we considered the hypothesis that c-Cbl might affect recycling of 5-HT 2A receptors. To study this possibility, we first determined whether 5-HT 2A receptors were associated with c-Cbl. Fig. 3 shows results from co-immunoprecipitation experiments, in which non-transfected HEK293 (NT) cells or cells transiently transfected with 5-HT 2A R were subjected to immunoprecipitation, followed by Western blotting of the c-Cbl. We did not observe any c-Cbl immunoreactivity in the immunoprecipitates from NT cells. In contrast, the endogenous c-Cbl was robustly coimmunoprecipitated with transiently expressed 5-HT 2A receptors (Fig. 3, second lane, top panel) , indicating an interaction between the two proteins. Our work does not distinguish whether this is a direct interaction, or whether it occurs through an intermediate biding partner.
Interaction of 5-HT
Role of c-Cbl in Agonist-induced 5-HT 2A R Trafficking-We next sought to determine whether the association of 5-HT 2A receptors with c-Cbl had any functional consequences on recycling. To test the possibility that c-Cbl might influence the recycling of 5-HT 2A R, we used a siRNA knockdown approach to selectively deplete endogenous c-Cbl (Fig. 4) . As shown in Fig. 4A 
Differential Association of c-Cbl Mutants with 5-HT 2A R-
Our microscopy studies presented in Fig. 4B clearly demonstrate that c-Cbl is involved in 5-HT 2A receptor trafficking. Because ubiquitin activity of c-Cbl is critical for agonist-induced EGFR degradation (14) and recycling (1), it was essential to investigate whether ubiquitin ligase activity of c-Cbl played any role in the recycling of the 5-HT 2A receptor. Accordingly, in the next set of experiments, we compared the effects of wildtype c-Cbl (c-Cbl-WT) with two C-terminal truncation c-Cbl mutants, i.e. c-Cbl-(1-436)-GFP, which maintained ubiquitin ligase activity and c-Cbl-N-GFP without ubiquitin ligase activity (Fig. 5A) .
First, we assessed the expression levels of truncated c-Cbl mutants by Western blotting (Fig. 5B) . Briefly, HEK293 cells were transiently transfected with the expression plasmids encoding c-Cbl-WT-GFP and two truncated mutants of c-Cbl also tagged with GFP. Following lysis of the cells, we determined in parallel the expression of all c-Cbl variants by immunoblotting with anti-GFP antibody. As seen in Fig. 5B , the three proteins were uniformly expressed in HEK293, with expected relative mobilities on a polyacrylamide gel. We further established whether c-Cbl mutants affected the expression levels of 5-HT-induced 5-HT 2A receptors (Fig. 5C) , and whether c-Cbl mutants maintained the previously observed interactions between 5-HT 2A R and c-Cbl (Fig. 5D) . To test this, we co-trans- (Fig. 5D) . Following immunoprecipitation of v5-tagged 5-HT 2A receptors, we observed that neither c-Cbl-WT nor c-Cbl mutants significantly altered the overall levels of 5-HT 2A receptors upon exposure to 5-HT (Fig. 5C ). Most importantly, however, the quantitative analysis of c-Cbl band intensities, normalized to the total 5-HT 2A R, revealed that in contrast to c-Cbl-WT (Fig. 5D, second and third lanes) , c-Cbl-(1-436) and c-Cbl-N (Fig. 5D , fourth and fifth and sixth and seventh lanes, respectively) associated poorly with the 5-HT 2A receptors. Interestingly, the interaction between the two proteins in cells transfected with wild-type c-Cbl remained unchanged despite exposure to 5-HT for 5 min (compare second and third lanes in Fig. 5D ) and lasted throughout the 180-min stimulation (data not shown). These results could indicate that 5-HT 2A receptors and c-Cbl constitutively interact with each other in the absence of the agonist. This work could also suggest that the C-terminal region of c-Cbl is mandatory for its interaction with 5-HT 2A receptors, and furthermore, that the decreased interaction between c-Cbl and 5-HT 2A R was independent of c-Cbl ubiquitin ligase activity. However, the situation is much more complex in that the truncation mutants both appear to function as dominant-negative constructs by preventing normal 5-HT 2A R recycling by endogenous c-Cbl.
Role of c-Cbl Carboxyl Terminus in 5-HT 2A R RecyclingNext, we investigated whether the carboxyl terminus of c-Cbl was involved in 5-HT 2A R intracellular trafficking. HEK293 cells overexpressing 5-HT 2A receptors and c-Cbl mutants were treated with a synchronized pulse of 1 M 5-HT and subsequently followed for 3 h. We found that expression of wild-type c-Cbl did not change the 5-HT 2A R intracellular processing profile (Fig. 6A, top panels) . Indeed, the synchronization studies revealed a pattern of receptor surface expression, which was similar to that obtained with the endogenous wild-type c-Cbl (compare Fig. 1A , bottom panels, 180 min, with Fig. 6 , A, top panels, c-Cbl-WT). In contrast, c-Cbl-N and cCbl-(1-436) did not induce changes in 5-HT 2A R internalization (data not shown), both mutants altered the degree of receptor recycling. These effects were clearly illustrated in confocal images, where 5-HT 2A receptors were found sequestered in tightly packed, centrally located intracellular vesicles (Fig. 6A, middle panels  for c-Cbl-N and bottom panels for c-Cbl-(1-436) ). Our confocal microscopy analysis was confirmed by quantitative measurements of 5-HT 2A R attenuated recycling. As seen in Fig. 6B (Fig. 6C ) and c-Cbl-(1-436) (data not shown) using dual-label confocal microscopy. To quantitatively assess the extent of 5-HT 2A receptor colocalization within subplasma membrane intracellular regions, we determined the colocalization coefficients in the same manner as previously described in Fig. 2B (see Fig. 6D ). These results demonstrate that expression of c-Cbl mutants lacking the carboxyl terminus lead to increased 5-HT 2A receptors from early endosomes to Rab11-containing recycling vesicles, and in the efficient recycling of 5-HT 2A receptor back to the plasma membrane. Fig. 6 we hypothesized that impaired trafficking of 5-HT 2A R in the presence of c-Cbl mutants could affect receptor responsiveness. To evaluate a potential functional significance of the interaction of 5-HT 2A receptors with c-Cbl, HEK293 cells transiently co-transfected with 5-HT 2A R and c-Cbl constructs were subjected to a synchronized ligand pulse. 5-HT 2A receptor responsiveness was subsequently assessed by analysis of Ca 2ϩ mobilization following exposure to either buffer ("untreated") or 1 M 5-HT ("postpulse") (Fig. 7) . As shown in Fig. 7A , 5-HT-induced ("postpulse") Ca 2ϩ mobilization in cells expressing c-Cbl-WT and 5-HT 2A R was not significantly altered following receptor trafficking in the absence ("veh") or presence ("5-HT") of an agonist. This suggests that expression of exogenous c-Cbl does not affect the rates of 5-HT 2A R resensitization. In contrast, consistent with our observations that both c-Cbl mutants lacking the carboxyl terminus altered receptor trafficking (Fig. 6A) , resensitization of 5-HT 2A receptors was significantly inhibited in the presence of c-Cbl-(1-436) or c-Cbl-N (Fig. 7, B and C, respectively). A similar observation was made when 5-HT 2A R resensitization was assessed under control and c-Cbl-knockdown conditions in HEK293 cells transiently expressing 5-HT 2A R; c-Cbl-knockdown significantly impaired 5-HT 2A receptor resensitization (supplemental Fig. S2 ). These results show a dramatic reduction in the peak amplitude of Ca 2ϩ mobilization between receptors that trafficked in the absence ("veh") and presence ("5-HT") of an agonist (see Fig. 7D and supplemental Fig. S2C for quantification) . It should be noted that no change was observed in the plateau phases of Ca 2ϩ mobilization. Together, the work in Fig. 7 demonstrates that the carboxyl terminus of c-Cbl is essential for effective 5-HT 2A R resensitization.
Role of Carboxyl Terminus of c-Cbl in 5-HT 2A R Resensitization-Based on our data in
DISCUSSION
It is now generally appreciated that one of the mechanisms of regulation of GPCR function involves receptor movement through endocytic pathway(s). Although much has been learned about the intracellular trafficking of GPCRs (9, 15) , many aspects of GPCR sorting machinery and specific proteins involved in determining the fate of GPCRs are incomplete. In this study, we investigated the roles of c-Cbl, the ubiquitin ligase known to regulate sorting and degradation of receptor tyrosine kinases, in 5-HT 2A R trafficking and receptor responsiveness. What is new about this work is that we show that c-Cbl is a mediator of recycling of the 5-HT 2A receptors to the plasma membrane. To the best of our knowledge, this is the first demonstration that c-Cbl mediates efficient exit of GPCRs from early endosomes into Rab11-positive recycling pathways. Our studies also implicate a role for c-Cbl in controlling GPCR resensitization.
It has been demonstrated that both agonists and antagonists induce endocytosis of 5-HT 2A R (16) . Although binding of ␤-arrestin proteins to phosphorylated receptors facilitates internalization of many GPCRs (2), it has been proposed that 5-HT 2A R endocytosis is arrestin-independent (17) . A previous study also implicated protein kinase C in agonist-induced 5-HT 2A R internalization (18) . Nevertheless, there are virtually no reports thus far in the literature characterizing post-endocytic intracellular trafficking of 5-HT 2A receptors. Following endocytosis, internalized receptors are sorted to either lysosomes to promote receptor proteolytic degradation, or to a recycling pathway to promote receptor return to the plasma membrane. In that regard, our results suggest that serotonin targets 5-HT 2A R to a Rab11-positive recycling pathway. It is worth noting, however, that following prolonged exposure to agonists, some recycling GPCRs, e.g. ␤ 2 -adrenergic receptors, can undergo significant down-regulation (9) . Intriguingly, we recently demonstrated that, unlike ␤ 2 -adrenergic receptors, sustained agonist stimulation induces 5-HT 2A R sequestration in the perinuclear region (19) , suggesting a more complex mechanism of 5-HT 2A R endocytic trafficking.
The most critical observation in the current studies is that knockdown of c-Cbl as well as overexpression of c-Cbl mutants, dysregulates 5-HT 2A R recycling. Our studies demonstrate that diminished 5-HT 2A R recycling coincides with inefficient interaction between c-Cbl and 5-HT 2A R and reduced transition of agonist-activated 5-HT 2A R from early endosomes to the Rab11-postive recycling endosomes. As much as these results are somewhat surprising due to known role of c-Cbl in mediating receptor targeting to lysosomal degradation (20) , they are consistent with our recent findings implicating c-Cbl as a critical mediator of active sorting of the EGFR to the recycling endosomes (1) . Together these findings suggest that c-Cbl may have a novel regulatory role in controlling a common checkpoint during sorting to the recycling pathway. It should be noted that c-Cbl appears to exhibit some specificity toward regulated versus constitutive intracellular endocytic pathways, i.e. knockdowns of c-Cbl had negligible effects on the constitutive trafficking of transferrin receptors (21) . Our results do not rule out a role for c-Cbl in the endocytosis of 5-HT 2A R, as we did not study the endocytotic process in detail.
One particularly surprising result of the current work is that the carboxyl-terminal domain of c-Cbl, but not necessarily c-Cbl ubiquitin ligase activity, is required for efficient trafficking and recycling of 5-HT 2A receptors to the plasma membrane. This was demonstrated by comparing the effects of wildtype c-Cbl with two, previously characterized (22), C-terminal truncation mutants of c-Cbl. The finding that c-Cbl effects on 5-HT 2A R recycling are independent of c-Cbl ligase activity is quite intriguing. Indeed, we found that 5-HT 2A R was continuously ubiquitinated (data not shown) in the absence or presence of the agonist (potentially caused by a high level of 5-HT 2A R constitutive trafficking (23)), yet both mutants, i.e. c-Cbl-(1-436)-GFP, which maintained ubiquitin ligase activity, and c-Cbl-N-GFP without ubiquitin ligase activity, had compromised 5-HT 2A R recycling. This warrants further investigation to determine whether c-Cbl is the ubiquitin ligase responsible for 5-HT 2A R ubiquitination and to determine the role of receptor ubiquitination in 5-HT 2A R trafficking and signaling.
The situation is complicated further by the observation that not only were the truncation mutants unable to support 5-HT 2A R recycling, but also showed dominant-negative characteristics in that they were capable of blocking the essential function of endogenous c-Cbl to support recycling. If the truncation mutants merely were unable to support recycling of the 5-HT 2A R, one might reasonably expect that native c-Cbl would be able to associate with the receptors leading to unaltered trafficking.
Although our work is consistent with a role for c-Cbl in selectively regulating 5-HT 2A R recycling, it is also possible that c-Cbl plays a more general role in vesicular trafficking. Indeed, the fact that two distinct c-Cbl mutants lose appropriate cellular localizations suggests perhaps a general recycling defect. On the other hand, our previous work showed that knockdown of c-Cbl had negligible effects on the constitutive trafficking of transferrin receptors (21) . Clearly, more work is needed to determine whether c-Cbl specifically modulates 5-HT 2A R recycling, or has more generalized effects on vesicle trafficking.
Nonetheless, our data point to a novel regulatory mechanism whereby an adaptor function for c-Cbl, rather than its ubiqutin ligase activity, seems to modulate 5-HT 2A R recycling. Indeed, the multidomain structure of c-Cbl allows it to interact with many partners. During recent years, ϳ150 proteins have been identified as targets of c-Cbl (24) . The C-terminal region of c-Cbl encompasses the major sites of tyrosine phosphorylation that enable interactions of c-Cbl with SH2 domain-containing proteins; as well as leucine zipper and ubiquitin-associated domains, which mediate dimerization of multiple proteins and bind to ubiquitin residues, respectively (25) . Interestingly, c-Cbl has been shown to regulate phosphorylation and the level of hepatocyte growth factor-regulated tyrosine kinase substrate (26) , which appears to be required for efficient recycling of some GPCRs (27, 28) . It is tempting to speculate that the c-Cbl carboxyl terminus bridges the interaction(s) between 5-HT 2A R and protein(s) that control efficient exit of cargo from the early endosomes into the recycling compartments. In addition, the fact that the c-Cbl truncation mutants block the recycling functions of endogenous c-Cbl suggests that the interactions between c-Cbl, the 5-HT 2A R, and other partners are highly complex. Future studies are needed to determine how the C terminus of c-Cbl regulates 5-HT 2A R trafficking and to identify other possible 5-HT 2A R/c-Cbl interacting partners.
It is now evident that receptor recycling pathways promote resensitization of receptor-mediated cellular responsiveness (9) . The functional significance of the role of c-Cbl in 5-HT 2A R recycling is evident in that c-Cbl is required for resensitization ( Fig. 7 and supplemental Fig. S2 ). This work is significant in that it demonstrates that c-Cbl, which typically mediates receptor degradation, also plays key roles in receptor recycling and resensitization of EGFR (1) . Indeed, we recently showed that members of the ESCRT complex, which is intimately involved in protein degradation, also controls recycling of EGF receptors (21) . Therefore, the current work adds to an emerging unsuspected paradigm that implicates proteins involved in receptor degradation (c-Cbl, ESCRT proteins) in receptor recycling and resensitization.
In summary, we have discovered a novel role for c-Cbl, the ubiquitin ligase typically associated with receptor degradation, in the recycling and resensitization of the 5-HT 2A receptor. This study demonstrates that: 1) 5-HT 2A receptors undergo specialized recycling to the plasma membrane through Rab11-positive vesicles, 2) the carboxyl terminus of c-Cbl, but not its ubiquitin ligase activity, is required for efficient exit of 5-HT 2A R from early endosomes into Rab11-positive vesicles, and 3) an interaction between 5-HT 2A R and carboxyl terminus of c-Cbl is critical for functional receptor recovery and responsiveness. Because dysregulated GPCR trafficking has been associated with a variety of human diseases (15) , future insights into the regulation of GPCR endocytic trafficking may provide new approaches for new therapeutic strategies.
